Stock NOVN NVN LIQUIDATION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages NVN Liquidation, Inc.

Equities

NOVN

US66988N2053

Market Closed - OTC Markets
Other stock markets
 01:02:31 01/05/2024 am IST 		5-day change 1st Jan Change
0.000001 USD -99.88% Intraday chart for NVN Liquidation, Inc. -.--% -99.80%
17/01 First Amended Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc. CI
2023 Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc.
First Motion for Exclusivity Period Extension Approved For NVN Liquidation, Inc.
First Motion for Exclusivity Period Extension Filed by NVN Liquidation, Inc.
Novan, Inc. Announces the Resignation of John M. Gay as Secretary
Ligand Pharmaceuticals Incorporated completed the acquisition of Substantially All of the Assets of Novan, Inc. for $12.2 million.
Motion for Joint Administration Approved for Novan, Inc.
Sector Update: Health Care Stocks Slipping Late Monday
Top Midday Decliners
Sector Update: Healthcare Stocks Easing Monday Afternoon
Novan Files for Chapter 11 Bankruptcy Protection, to Sell Nearly All Assets to Ligand Pharmaceuticals
Motion for Joint Administration Filed by Novan, Inc.
Novan, Inc. Filed for Bankruptcy
Novan, Inc. Announces Board Changes
Novan to Cut Workforce by 50% Amid Restructuring
Novan, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Novan, Inc. Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement
Novan, Inc. Announces Principal Financial Officer Changes
Novan, Inc. Auditor Raises 'Going Concern' Doubt
Novan Says US FDA Accepted New Drug Application for Berdazimer Gel to Treat Molluscum Contagiosum
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NOVN Stock
  4. News NVN Liquidation, Inc.
  5. Other languages